ArticleJCO global oncology2025

Oral Cyclophosphamide for Patients With Metastatic Castration-Resistant Prostate Cancer in a Scenario of Limited Health Care Resources.

Diana Del Cisne Pineda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.